# Imaging and Biological Markers for Prediction and Identification of Glioblastoma Pseudoprogression: a Prospective Study.

> **NCT06113705** · NA · RECRUITING · sponsor: **Istituto Clinico Humanitas** · enrollment: 75 (estimated)

## Conditions studied

- Glioblastoma

## Interventions

- **DIAGNOSTIC_TEST:** 18F-GE-180 PET
- **DIAGNOSTIC_TEST:** Advanced MRI
- **OTHER:** Collection of hematopoietic stem cells
- **OTHER:** Blood withdrawal
- **OTHER:** Collection of Cancer Stem Cells

## Key facts

- **NCT ID:** NCT06113705
- **Lead sponsor:** Istituto Clinico Humanitas
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-11-01
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 75 (ESTIMATED)
- **Last updated:** 2025-01-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06113705

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06113705, "Imaging and Biological Markers for Prediction and Identification of Glioblastoma Pseudoprogression: a Prospective Study.". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT06113705. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*